These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Danazol therapy in immune thrombocytopenic purpura.
    Author: Marwaha RK, Singh RP, Garewal G, Marwaha N, Prakash D, Sarode R.
    Journal: Pediatr Hematol Oncol; 1990; 7(2):193-8. PubMed ID: 2206861.
    Abstract:
    Nine children with chronic refractory immune thrombocytopenic purpura and moderate to severe episodes of bleeding were treated with Danazol in an attempt to increase their platelet counts and improve clinical hemostasis. Only one patient experienced an excellent response while a good response was obtained in another. Cessation of bleeding episodes was observed in two other children with only marginal increases in platelet counts. Four of the nine patients failed to show any clinical or hematological improvement. The drug was well tolerated but its efficacy in childhood ITP needs further evaluation.
    [Abstract] [Full Text] [Related] [New Search]